Skip to main content
Clinical Trials/NCT05540613
NCT05540613
Recruiting
Not Applicable

Tai Chi Versus Conventional Exercise to Improve Cognitive Performance in Older Adults With Mild Cognitive Impairment (MCI): A Comparative Randomized Controlled Trial

The University of Hong Kong1 site in 1 country315 target enrollmentNovember 1, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Mild Cognitive Impairment
Sponsor
The University of Hong Kong
Enrollment
315
Locations
1
Primary Endpoint
The score of the Montreal Cognitive Assessment (MoCA)
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

This randomized controlled trial aims to evaluate the effectiveness of Tai Chi and conventional exercise on improving cognitive function in older adults with mild cognitive impairment (MCI). Participants will be randomized into three six-month programmes, namely Health Education group, Tai Chi group and Conventional Exercise group. Assessments will be conducted at baseline, after the 26-week interventions, and 26-week after the competition of the intervention.

Registry
clinicaltrials.gov
Start Date
November 1, 2022
End Date
January 2026
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Chinese older adults aged equal or larger than 50 years
  • Ethnic Chinese
  • MCI under criteria of Mayo Clinic, including the following
  • i. people with subjective complaint about a decline in cognitive function. ii. total score in the Montreal Cognitive Assessment is equal or below the 7th percentile of the age- and education- corrected normative data of Hong Kong. iii. the decline in cognitive function does not impair daily functioning, as revealed by getting ≥2 marks in every item on the Chinese Lawton Instrumental Activities of Daily Living 4-point Scale).

Exclusion Criteria

  • medical history of major chronic diseases such as cancer, stroke, cerebro- and cardio-vascular diseases, and renal disease
  • uncontrolled diabetes
  • diagnosed with dementia or using anti-dementia medication
  • diagnosed with psychiatric diseases or using psychiatric medication
  • with diseases or on medications known to severely affect cognitive performance
  • somatic condition (e.g., limb lost) that prevent participation in exercise
  • impaired mobility by chronic diseases (e.g., neurological, musculoskeletal and autoimmune diseases)
  • incapable to perform physical exercise
  • regular exercise habit (\>3 times 60-min Tai Chi or moderate-intensity conventional exercise weekly) in the past 3 months

Outcomes

Primary Outcomes

The score of the Montreal Cognitive Assessment (MoCA)

Time Frame: 52 weeks

Change in the score of the Montreal Cognitive Assessment. The score ranged from 0 to 30. Higher score indicates a better cognitive function. Participants scoring equal or below the 7th percentile of the age- and education-corrected normative data will be considered as having MCI.

Secondary Outcomes

  • Clinical Dementia Rating(26 weeks and 52 weeks)
  • Neurocognitive Test(26 weeks and 52 weeks)
  • The 12-Item Short Form Survey(26 weeks and 52 weeks)
  • Subjective Cognitive Performance(26 weeks and 52 weeks)
  • Medication Use(26 weeks and 52 weeks)
  • Short Physical Performance Battery (SPPB) Test(26 weeks and 52 weeks)
  • Habitual Physical Activity(26 weeks and 52 weeks)
  • Subjective Memory complaints(26 weeks and 52 weeks)
  • The Hospital Anxiety and Depression Scale(26 weeks and 52 weeks)
  • Subjective Sleep Quality(26 weeks and 52 weeks)

Study Sites (1)

Loading locations...

Similar Trials